✦ LIBER ✦

The significance of HER-2/neu receptor positivity and immunophenotype in ductal carcinoma in situ with early invasive disease

✍ Scribed by Shuko Harada; Rosemarie Mick; Robert E. Roses; Holly Graves; Huilin Niu; Anupama Sharma; Jeanne E. Schueller; Harvey Nisenbaum; Brian J. Czerniecki; Paul J. Zhang

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 282 KB
Volume: 104
Category: Article
ISSN: 0022-4790
DOI: 10.1002/jso.21973

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Residual disease after re-excision for t

Residual disease after re-excision for tumour-positive surgical margins in both ductal carcinoma in situ and invasive carcinoma of the breast: The effect of time

✍ A.P. Schouten van der Velden; Simon L.B. Van de Vrande; Carla Boetes; Peter Bult 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

Serum HER-2/neu conversion to positive a

Serum HER-2/neu conversion to positive at the time of disease progression in patients with breast carcinoma on hormone therapy

✍ Allan Lipton; Kim Leitzel; Suhail M. Ali; Laurence Demers; Harold A. Harvey; Hil 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 1 views

A comparison of five immunohistochemical

A comparison of five immunohistochemical biomarkers and HER-2/neu gene amplification by fluorescence in situ hybridization in white and Korean patients with early-onset breast carcinoma

✍ Doo Ho Choi; Dong Bok Shin; Min Hyuk Lee; Dong Wha Lee; Devika Dhandapani; Darry 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

## Abstract ## BACKGROUND The objective of this article was to compare five tumor markers between white women in the U.S. and native Korean women with early‐onset breast carcinoma. ## METHODS Sixty Korean women who were diagnosed with breast carcinoma at age 45 years or younger and 60 white wome

HER-2/neu status and tumor morphology of

HER-2/neu status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA1 mutation status in the Ontario Familial Breast Cancer Registry

✍ Louise A. Quenneville; Kelly-Anne Phillips; Hilmi Ozcelik; Robert K. Parkes; Jul 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 1 views

## Abstract ## BACKGROUND The prevalence of BRCA1 germline mutations is greater in the Ashkenazi Jewish population than in the general North American population. The Ontario Familial Breast Cancer Registry collects clinical and family history data in familial breast carcinoma cases, and unselected